List of Tables
    Table 1. Novel Vaccine Delivery Systems Market Opportunities & Trends in Global Market
    Table 2. Novel Vaccine Delivery Systems Market Drivers in Global Market
    Table 3. Novel Vaccine Delivery Systems Market Restraints in Global Market
    Table 4. Key Players of Novel Vaccine Delivery Systems in Global Market
    Table 5. Top Novel Vaccine Delivery Systems Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Novel Vaccine Delivery Systems Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Novel Vaccine Delivery Systems Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Novel Vaccine Delivery Systems Product Type
    Table 9. List of Global Tier 1 Novel Vaccine Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Novel Vaccine Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Novel Vaccine Delivery Systems Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Novel Vaccine Delivery Systems Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2023-2028
    Table 30. Altaris Capital Partners Corporate Summary
    Table 31. Altaris Capital Partners Novel Vaccine Delivery Systems Product Offerings
    Table 32. Altaris Capital Partners Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 33. Kindeva Drug Delivery Corporate Summary
    Table 34. Kindeva Drug Delivery Novel Vaccine Delivery Systems Product Offerings
    Table 35. Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 36. Becton Corporate Summary
    Table 37. Becton Novel Vaccine Delivery Systems Product Offerings
    Table 38. Becton Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 39. Dickinson, Corporate Summary
    Table 40. Dickinson, Novel Vaccine Delivery Systems Product Offerings
    Table 41. Dickinson, Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 42. Carl Zeiss Foundation Corporate Summary
    Table 43. Carl Zeiss Foundation Novel Vaccine Delivery Systems Product Offerings
    Table 44. Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 45. Gerresheimer AG Corporate Summary
    Table 46. Gerresheimer AG Novel Vaccine Delivery Systems Product Offerings
    Table 47. Gerresheimer AG Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 48. Corium International Corporate Summary
    Table 49. Corium International Novel Vaccine Delivery Systems Product Offerings
    Table 50. Corium International Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 51. Inovio Pharmaceuticals Corporate Summary
    Table 52. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product Offerings
    Table 53. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 54. Bioject Medical Technologies Corporate Summary
    Table 55. Bioject Medical Technologies Novel Vaccine Delivery Systems Product Offerings
    Table 56. Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 57. PharmaJet Corporate Summary
    Table 58. PharmaJet Novel Vaccine Delivery Systems Product Offerings
    Table 59. PharmaJet Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 60. Retractable Technologies Corporate Summary
    Table 61. Retractable Technologies Novel Vaccine Delivery Systems Product Offerings
    Table 62. Retractable Technologies Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 63. Terumo Corporation Corporate Summary
    Table 64. Terumo Corporation Novel Vaccine Delivery Systems Product Offerings
    Table 65. Terumo Corporation Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
    Table 66. VAXXAS Corporate Summary
    Table 67. VAXXAS Novel Vaccine Delivery Systems Product Offerings
    Table 68. VAXXAS Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Novel Vaccine Delivery Systems Segment by Type in 2021
    Figure 2. Novel Vaccine Delivery Systems Segment by Application in 2021
    Figure 3. Global Novel Vaccine Delivery Systems Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Novel Vaccine Delivery Systems Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Novel Vaccine Delivery Systems Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Novel Vaccine Delivery Systems Revenue in 2021
    Figure 8. By Type - Global Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
    Figure 12. US Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
    Figure 16. Germany Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 17. France Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
    Figure 24. China Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 28. India Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
    Figure 30. Brazil Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
    Figure 33. Turkey Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
    Figure 37. Altaris Capital Partners Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Becton Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Dickinson, Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Gerresheimer AG Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Corium International Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. PharmaJet Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Retractable Technologies Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Terumo Corporation Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. VAXXAS Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)